Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Q-Cells SE To File For Insolvency - Quick Facts

Q-Cells SE (QCLSF.PK) would file for insolvency proceedings on Tuesday, 3 April 2012, at the competent Insolvency Court in Dessau. Against the backdrop of the final ruling of the Frankfurt Higher Regional Court in the Pfleiderer case on March 27, 2012, the company had come to the conclusion that no going concern prognosis is given anymore.

After an intensive review of alternative concepts for the implementation of the financial restructuring, the Executive Board has concluded that a going concern of the company cannot be restored on a sufficiently secure legal basis. Hence, the filing for insolvency proceedings is legally necessary. The Executive Board and the preliminary insolvency administrator would work together to secure the continuity of the company within the insolvency proceedings.

Click here to receive FREE breaking news email alerts for Q-Cells SE and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.